Devonian Health Group is trading at CA$10.15, down -8.97%, with no new company-specific announcement identified to explain the August 20, 2026 decline.
- The move follows gains of 27.04% on August 18 and 10.40% on August 19, when investors reacted to Devonian’s planned NYSE American listing.
- The listing is expected as early as August 21, subject to final authorization and market conditions.
- Broader markets are modestly weaker while biotechnology is stronger, so sector or global conditions do not clearly explain today’s drop.